A unified procedure for meta-analytic evaluation of surrogate end points in randomized clinical trials

ISSN： 1465-4644

Source： Biostatistics, Vol.13, Iss.4, 2012-09, pp. : 609-624

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical trials and surrogate end points: lessons from the ENHANCE trial

By Farmer John Alan

Future Lipidology, Vol. 3, Iss. 4, 2008-08 ,pp. : 353-357

Future Medicine

Access to resources Recommend Favorite

On meta-analytic assessment of surrogate outcomes

By Gail M.H.

Biostatistics, Vol. 1, Iss. 3, 2000-09 ,pp. : 231-246

Oxford University Press

Access to resources Recommend Favorite

A simple meta-analytic approach for using a binary surrogate endpoint to predict the effect of intervention on true endpoint

By Baker Stuart G.

Biostatistics, Vol. 7, Iss. 1, 2006-01 ,pp. : 58-70

Oxford University Press

Access to resources Recommend Favorite

Variability in Meta-Analytic Effect Sizes and Meta-Analysis Outcomes as a Function of Measurement Procedure

By Nugent William R. Ely Gretchen E.

Best Practices in Mental Health, Vol. 4, Iss. 2, 2008-07 ,pp. : 80-98

Lyceum Books

Access to resources Recommend Favorite

Use of Recursive Partitioning Analysis in Clinical Trials and Meta-Analysis of Randomized Clinical Trials, 1990-2016

Reviews on Recent Clinical Trials, Vol. 12, Iss. 1, 2017-01 ,pp. : 3-7

Bentham Science Publishers

Access to resources Recommend Favorite